Exact FDA event identifier

Event 75700

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: October 18, 2016
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: Town and Country Compounding and Consultation Services, LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & Country, Compounding & Consultation Services, 106 Prospect St - 1st FL, Ridgewood, NJ 07459

D-0436-2017

Recall number: D-0436-2017
Initiated: October 18, 2016
Classification: Class III
Status: Terminated
Recalling firm: Town and Country Compounding and Consultation Services, LLC
Quantity: 101 vials

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).

Code information

Lot #: 05272016@17

Distribution pattern

Nationwide